Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1987-10-7
pubmed:abstractText
Bordetella pertussis Tohama phases I and III were grown to the late-exponential phase in liquid medium containing [3H]diaminopimelic acid and treated by a hot (96 degrees C) sodium dodecyl sulfate extraction procedure. Washed sodium dodecyl sulfate-insoluble residue from phases I and III consisted of complexes containing protein (ca. 40%) and peptidoglycan (60%). Subsequent treatment with proteinase K yielded purified peptidoglycan which contained N-acetylglucosamine, N-acetylmuramic acid, alanine, glutamic acid, and diaminopimelic acid in molar ratios of 1:1:2:1:1 and less than 2% protein. Radiochemical analyses indicated that 3H added in diaminopimelic acid was present in peptidoglycan-protein complexes and purified peptidoglycan as diaminopimelic acid exclusively and that pertussis peptidoglycan was not O acetylated, consistent with it being degraded completely by hen egg white lysozyme. Muramidase-derived disaccharide peptide monomers and peptide-cross-linked dimers and higher oligomers were isolated by molecular-sieve chromatography; from the distribution of these peptidoglycan fragments, the extent of peptide cross-linking of both phase I and III peptidoglycan was calculated to be ca. 48%. Unambiguous determination of the structure of muramidase-derived peptidoglycan fragments by fast atom bombardment-mass spectrometry and tandem mass spectrometry indicated that the pertussis peptidoglycan monomer fraction was surprisingly homogeneous, consisting of greater than 95% N-acetylglucosaminyl-N-acetylmuramyl-alanyl-glutamyl-diaminopimelyl++ +-alanine.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-1083878, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-112060, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-3084386, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-3108252, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-362430, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-3871106, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-3881387, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-3924833, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-3924898, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-4324651, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-4597063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-478648, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6177637, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6406367, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6417014, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6425421, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6490636, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6772568, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6776063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-6799403, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-7021156, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-7054119, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-7056735, http://linkedlifedata.com/resource/pubmed/commentcorrection/2887547-812088
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
169
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4223-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Structure of Bordetella pertussis peptidoglycan.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.